Cormorant Asset Management as of Dec. 31, 2013
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 37 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 10.1 | $35M | 547k | 63.82 | |
| Cubist Pharmaceuticals | 8.0 | $28M | 400k | 68.87 | |
| Keryx Biopharmaceuticals | 6.4 | $22M | 1.7M | 12.95 | |
| Dyax | 6.2 | $22M | 2.9M | 7.54 | |
| Puma Biotechnology (PBYI) | 6.0 | $21M | 200k | 103.53 | |
| Celgene Corporation | 5.9 | $20M | 120k | 168.97 | |
| ACADIA Pharmaceuticals (ACAD) | 5.8 | $20M | 800k | 24.99 | |
| Idenix Pharmaceuticals | 5.1 | $18M | 2.9M | 5.98 | |
| Geron Corporation (GERN) | 4.7 | $16M | 3.4M | 4.74 | |
| Alnylam Pharmaceuticals (ALNY) | 4.7 | $16M | 250k | 64.30 | |
| Bristol Myers Squibb (BMY) | 4.2 | $14M | 270k | 53.15 | |
| Arrowhead Research | 3.1 | $11M | 996k | 10.85 | |
| Dex (DXCM) | 3.1 | $11M | 300k | 35.41 | |
| Receptos | 2.9 | $10M | 350k | 28.99 | |
| Array BioPharma | 2.5 | $8.8M | 1.8M | 5.01 | |
| Acelrx Pharmaceuticals | 2.5 | $8.5M | 750k | 11.31 | |
| Tesaro | 2.5 | $8.5M | 300k | 28.24 | |
| Clovis Oncology | 2.1 | $7.2M | 119k | 60.27 | |
| BioMarin Pharmaceutical (BMRN) | 2.0 | $7.0M | 100k | 70.35 | |
| Alkermes | 1.8 | $6.1M | 150k | 40.66 | |
| AMAG Pharmaceuticals | 1.8 | $6.1M | 250k | 24.28 | |
| Insulet Corporation (PODD) | 1.6 | $5.6M | 150k | 37.10 | |
| Novavax | 1.5 | $5.1M | 1.0M | 5.12 | |
| Pacira Pharmaceuticals (PCRX) | 0.8 | $2.9M | 50k | 57.50 | |
| Sangamo Biosciences (SGMO) | 0.7 | $2.3M | 166k | 13.89 | |
| Karyopharm Therapeutics (KPTI) | 0.7 | $2.3M | 100k | 22.92 | |
| Chimerix (CMRX) | 0.6 | $2.2M | 143k | 15.11 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $2.0M | 268k | 7.60 | |
| Portola Pharmaceuticals | 0.6 | $1.9M | 75k | 25.75 | |
| Osiris Therapeutics | 0.5 | $1.7M | 108k | 16.08 | |
| XenoPort | 0.3 | $1.2M | 200k | 5.75 | |
| Regulus Therapeutics | 0.2 | $739k | 100k | 7.39 | |
| Momenta Pharmaceuticals | 0.1 | $490k | 28k | 17.69 | |
| Ptc Therapeutics I (PTCT) | 0.1 | $489k | 29k | 16.98 | |
| Dendreon Corporation | 0.1 | $449k | 150k | 2.99 | |
| Five Prime Therapeutics | 0.1 | $336k | 20k | 16.80 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $273k | 10k | 27.30 |
